Abderrazzak Merzouki
Chief Tech/Sci/R&D Officer chez SUNSHINE BIOPHARMA, INC.
Fortune : 7 003 $ au 31/03/2024
Profil
Abderrazzak Merzouki is currently the Chief Science Officer & Director at Sunshine Biopharma, Inc. since 2016.
He is also currently a Senior Scientist at Imperial College London since 2007.
Previously, he worked as the Director-Cell Engineering & Biotherapeutics at Hydrogen Future Corp.
Dr. Merzouki holds a graduate and doctorate degree from the University of Quebec and a doctorate degree from Institut Armand-Frappier.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2024 | 116 720 ( 0,12% ) | 7 003 $ | 31/03/2024 |
Postes actifs de Abderrazzak Merzouki
| Sociétés | Poste | Début |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 25/01/2024 |
| Imperial College London | Corporate Officer/Principal | 04/02/2011 |
Anciens postes connus de Abderrazzak Merzouki
| Sociétés | Poste | Fin |
|---|---|---|
| HYDROGEN FUTURE CORP | Corporate Officer/Principal | - |
Formation de Abderrazzak Merzouki
| University of Quebec | Doctorate Degree |
| Institut Armand-Frappier | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Hydrogen Future Corp.
 Hydrogen Future Corp. Agricultural Commodities/MillingProcess Industries Hydrogen Future Corp. operates as a holding company. The firm engages in the provision of contract research and laboratory services. It provides alternate energy generation products and services. The company was founded on June 21, 2006 and is headquartered in Houston, TX. | Process Industries |
